Citeline Podcasts

In this episode, HBW Insight takes a bird’s eye view of sustainability in the cosmetics industry with HBW Insight Executive Editor Ryan Nelson. We discuss the drivers of sustainability efforts such as consumer demand for more eco-friendly products and the growing social consciousness about climate. We also discuss what steps companies are taking to make their products more sustainable, how the beauty industry is using third party regulatory groups to combat greenwashing, as well as the legislation in the US and UK that is putting pressure on businesses.

Scrip’s Five Must-Know Things – 4 April 2022 by Citeline

In this episode of Device Week: US lawmakers grilled FDA device center director Jeff Shuren on 30 March about the agency’s approach to putting together the latest user-fee agreement between industry and FDA.

Medtech Insight articles addressing topics discussed in this episode:

• FDA’s Shuren Grilled About Handling Of MDUFA V At House Hearing

• Lifting The Hood On MDUFA V

Pink Sheet reporter and editors discuss lessons from the FDA’s advisory committee on Amylyx’s ALS drug, the FDA’s proposed FY 2023 budget surge, and the ongoing effort to change the CMS coverage decision on Aduhelm.

In this episode, HBW Insight catches up with Association of the European Self-Care Industry, AESGP, director general Jurate Švarcaite to chat about the association’s upcoming Annual Meeting. The 58th Annual Meeting will be the first since the coronavirus pandemic that will take place in person, at the Hotel Meliá Castilla in Madrid, Spain, from the 7th to the 8th June. Bringing together more than 300 delegates from the consumer health industry, partner organisations and policymakers, topics will include self-care market trends, regulatory innovations seen during the pandemic, sustainability and advertising. There will also be plenty of time for networking between sessions and at the opening evening, something that has been sorely missed and is a key highlight of the AESGP Annual Meetings.

Scrip’s Five Must-Know Things – 28 March 2022 by Citeline

Scrip’s Five Must-Know Things – 22 March 2022 by Citeline

Welcome to Pharmaprojects’ 2022 review of trends in pharmaceutical R&D.

For 30 years now, we’ve been taking an annual look at the evolution of pharma R&D, and in this audiobook, we examine the state of play at the start of 2022.

Pink Sheet reporter and editors discuss a grassroots campaign against coverage of a controversial Alzheimer’s treatment, the potential for drug pricing reform, and the pandemic effects on FDA hiring and retention.

In this episode of Speaking Of Medtech: Too often quality is overshadowed by regulatory and compliance, and some manufacturers view quality as an obstacle to getting product into the marketplace rather than a concept that will help a company save money, reputation, and patient lives.

Medtech Insight articles addressing topics discussed in this episode:

• Quality Control & Compliance